As institutional capital enters cannabis, workforce risk is reshaping valuations. Learn why HR compliance and culture now ...
The era of the extract artist is over. Cannabis hit $33.8B in sales, but many operators still lack systems for scale. Here's ...
The AdvisorShares Pure US Cannabis ETF is rated a buy, driven by real regulatory progress and potential further catalysts.
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP examine the dual developments over the federal government ...
A first-of-its-kind state report finds emergency room visits for cannabis poisoning nearly doubled since 2016, with toddlers ...
The sale of and purchase of cannabis in Virginia remains, as far as most anyone can tell, illegal. That’s despite confusion ...
Stephen Lankenau has spent years studying how people use cannabis in everyday life. As director of Drexel University’s Medical Cannabis Research Center, he has watched legalization spread, products ...
Smoking is the most popular form of cannabis use, but it's also the most dangerous. Here are five safer alternatives to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results